Methods of treatment using D-serine
US9040581B1 · kind B1 · utility
7Cited by
3References
20Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Feb 20, 2014 |
| Grant date | May 26, 2015 |
| Priority date | — |
| Expiry date | Feb 20, 2034 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P25/08
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Methods of treatment using D-serine to target brain cells expressing GluN3 subunit-containing triheteromeric NMDARs are disclosed. The methods include inhibiting calcium ion uptake by brain cells, treating epilepsy, and treating seizures by artificially administering D-serine.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.